More information and a recording of the talk is available below.

For questions about this event, please reach out to Mary Christie at mchristie@health.missouri.edu

The Evolving Role of Precision Medicine in Lung Cancer

Description

Presented by Dr. Richard Hammer, Vice-Chair of Clinical Affairs, Dept of Pathology & Anatomical Sciences, and Kali Dougherty MS, CGC (Foundation Medicine)

The seminar:
•    Outlines the clinical implications of tumor testing strategies for patients with lung cancer, including comprehensive genomic profiling, hotspot analysis, tissue and liquid biopsies
•    Identifies the role of multidisciplinary teams in facilitation and implementation of molecular testing in oncology care settings
•    Assesses methods to overcome barriers to personalized medicine and increase molecular testing, tumor boards, and clinical trial referral in the community setting
•    Applies available molecular testing to develop evidence-based individualized treatment decisions for cancer patients
•    Reviews recent advancements in comprehensive genomic profiling for advanced lung cancer
•    Discusses potential applications of liquid biopsy for patients with advanced lung cancer and review available resources for physicians utilizing comprehensive genomic profiling